(Q46800173)

25 December 2017

title

A new method of selective intra-arterial infusion therapy via the superficial temporal artery for head and neck cancer (English)

1 reference

25 December 2017

author name string

Nobukazu Fuwa

1

1 reference

25 December 2017

Takeshi Kodaira

2

1 reference

25 December 2017

Kazuhisa Furutani

3

1 reference

25 December 2017

Hiroyuki Tachibana

4

1 reference

25 December 2017

Tatsuya Nakamura

5

1 reference

25 December 2017

publication date

21 February 2008

1 reference

25 December 2017

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

25 December 2017

volume

105

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

783-789

1 reference

25 December 2017

Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Perfusion and infusion techniques in cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Continuous arterial infusion of head and neck tumors; improvements in technique by retrograde temporal artery catheterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Combined intra-arterial infusion and radiotherapy for the treatment of advanced cancer of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Regional chemotherapy with combined drugs in cancer of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Induction intra-arterial cisplatin and bleomycin in head and neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

A pilot study of intraarterial chemotherapy with cisplatin in locally advanced head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Superselective intraarterial chemotherapy in combination with irradiation: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Continuous selective intraarterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

A novel approach to advanced carcinoma of the tongue: cases successfully treated with combination of superselective intra-arterial chemotherapy and external/high-dose-rate interstitial radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Response to intraarterial induction chemotherapy: a prognostic parameter in oral and oropharyngeal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Selective intraarterial chemotherapy of tumors in the lingual artery territory by a new approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Carcinoma of the oral tongue and floor of mouth: fifteen years' experience with linear acceleration therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Results of brachytherapy for cancer of the tongue with special emphasis on local prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Experience of the curie institute in treatment of cancer of the mobile tongue. I. Treatment policies and result

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Combined-modality treatment for advanced oral tongue squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Analysis of treatment results for oral tongue cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.07.031

10.1016/J.TRIPLEO.2007.07.031

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017